{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:21:59Z","timestamp":1792632119736,"version":"4.5.0"},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2024,12,25]]},"DOI":"10.1253\/circj.cj-24-0479","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T22:10:47Z","timestamp":1727993447000},"page":"24-30","source":"Crossref","is-referenced-by-count":19,"title":["Prospective Multicenter Screening With High-Sensitivity Cardiac Troponin T for Wild-Type Transthyretin Cardiac Amyloidosis in Outpatient and Community-Based Settings"],"prefix":"10.1253","volume":"89","author":[{"given":"Naoki","family":"Arima","sequence":"first","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Murakami","sequence":"additional","affiliation":[{"name":"Murakami Clinic Murakami Naika Junnkannkika"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Nishino","sequence":"additional","affiliation":[{"name":"Nishino Naika Clinic Junkanki Shinzounaika"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Yamamoto Junkanki Naika Ganka Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Satou","sequence":"additional","affiliation":[{"name":"Satou Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Tamura","sequence":"additional","affiliation":[{"name":"Tamura Cardio Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Okawa","sequence":"additional","affiliation":[{"name":"Okawa-Naika"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takata","sequence":"additional","affiliation":[{"name":"Aoyagi Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Ryosekihotarugaoka Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. <i>Circulation<\/i> 2012; 126: 1286\u20131300.","DOI":"10.1161\/CIRCULATIONAHA.111.078915"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. <i>Circ J<\/i> 2020; 84: 1610\u20131671.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sekijima Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. <i>Amyloid<\/i> 2018; 25: 8\u201310.","DOI":"10.1080\/13506129.2017.1409706"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin. <i>Circulation<\/i> 2016; 133: 282\u2013290.","DOI":"10.1161\/CIRCULATIONAHA.115.018852"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, et al. Clinicopathological features of senile systemic amyloidosis: An ante- and post-mortem study. <i>Mod Pathol<\/i> 2011; 24: 1533\u20131544.","DOI":"10.1038\/modpathol.2011.117"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gonz\u00e1lez-L\u00f3pez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. <i>Eur Heart J<\/i> 2015; 36: 2585\u20132594.","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. <i>JACC Heart Fail<\/i> 2014; 2: 113\u2013122.","DOI":"10.1016\/j.jchf.2013.11.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Longhi S, Lorenzini M, Gagliardi C, Milandri A, Marzocchi A, Marrozzini C, et al. Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis. <i>JACC Cardiovasc Imaging<\/i> 2016; 9: 325\u2013327.","DOI":"10.1016\/j.jcmg.2015.04.012"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, et al. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis. <i>ESC Heart Fail<\/i> 2018; 5: 27\u201335.","DOI":"10.1002\/ehf2.12203"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Yamanaka S, et al. Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: A case-control study. <i>BMC Cardiovasc Disord<\/i> 2015; 15: 53.","DOI":"10.1186\/s12872-015-0043-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Marume K, Takashio S, Nishi M, Hirakawa K, Yamamoto M, Hanatani S, et al. Combination of commonly examined parameters is a useful predictor of positive <sup>99 m<\/sup>Tc-labeled pyrophosphate scintigraphy findings in elderly patients with suspected transthyretin cardiac amyloidosis. <i>Circ J<\/i> 2019; 83: 1698\u20131708.","DOI":"10.1253\/circj.CJ-19-0255"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, et al. Validation of the Kumamoto criteria for prediction of 99 m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi. <i>J Cardiol<\/i> 2021; 77: 124\u2013130.","DOI":"10.1016\/j.jjcc.2020.06.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kligfield P, Gettes LS, Bailey JJ, Childers R, Deal BJ, Hancock EW, et al. Recommendations for the standardization and interpretation of the electrocardiogram: Part I: The electrocardiogram and its technology: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society endorsed by the International Society for Computerized Electrocardiology. <i>J Am Coll Cardiol<\/i> 2007; 49: 1109\u20131127.","DOI":"10.1161\/CIRCULATIONAHA.106.180200"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: Recommendations from the American Society of Echocardiography. <i>J Am Soc Echocardiogr<\/i> 2019; 32: 1\u201364.","DOI":"10.1016\/j.echo.2018.06.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Liu D, Hu K, Niemann M, Herrmann S, Cikes M, St\u00f6rk S, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. <i>Circ Cardiovasc Imaging<\/i> 2013; 6: 1066\u20131072.","DOI":"10.1161\/CIRCIMAGING.113.000683"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Perugini E, Guidalotti PL, Salvi F, Cooke RMT, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using <sup>99 m<\/sup>Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. <i>J Am Coll Cardiol<\/i> 2005; 46: 1076\u20131084.","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99 m pyrophosphate cardiac imaging: Predicting survival for patients with ATTR cardiac amyloidosis. <i>JAMA Cardiol<\/i> 2016; 1: 880\u2013889.","DOI":"10.1001\/jamacardio.2016.2839"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bokhari S, Casta\u00f1o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. <sup>99 m<\/sup>Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. <i>Circ Cardiovasc Imaging<\/i> 2013; 6: 195\u2013201.","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, et al. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. <i>Circ Heart Fail<\/i> 2019; 12: e006075.","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases. <i>Eur Heart J<\/i> 2021; 42: 1554\u20131568.","DOI":"10.1093\/eurheartj\/ehab072"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vergaro G, Castiglione V, Aimo A, Prontera C, Masotti S, Musetti V, et al. N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis. <i>Eur J Heart Fail<\/i> 2023; 25: 335\u2013346.","DOI":"10.1002\/ejhf.2769"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sugiura K, Kozuki H, Ueba H, Kubo T, Ochi Y, Baba Y, et al. Tenosynovial and cardiac transthyretin amyloidosis in Japanese patients undergoing carpal tunnel release. <i>Circ Rep<\/i> 2021; 3: 338\u2013344.","DOI":"10.1253\/circrep.CR-21-0046"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mohamed-Salem L, Santos-Mateo JJ, Sanchez-Serna J, Hern\u00e1ndez-Vicente \u00c1, Reyes-Marle R, Castell\u00f3n S\u00e1nchez MI, et al. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. <i>Int J Cardiol<\/i> 2018; 270: 192\u2013196.","DOI":"10.1016\/j.ijcard.2018.06.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M, et al. Identification of TTR-related subclinical amyloidosis with <sup>99 m<\/sup>Tc-DPD scintigraphy. <i>JACC Cardiovasc Imaging<\/i> 2014; 7: 531\u2013532.","DOI":"10.1016\/j.jcmg.2014.03.004"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Aimo A, Vergaro G, Castiglione V, Fabiani I, Barison A, Gentile F, et al. Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: The CATCH Screening Study. <i>Eur J Prev Cardiol<\/i> 2024; 31: 1410\u20131417, doi:10.1093\/eurjpc\/zwae093.","DOI":"10.1093\/eurjpc\/zwae093"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/1\/89_CJ-24-0479\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T03:18:22Z","timestamp":1735355902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/1\/89_CJ-24-0479\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0479","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,25]]},"article-number":"CJ-24-0479"}}